LDLR and metabolic dysfunction-associated steatotic liver disease: We conclude that inhibition of ceramide biosynthesis protects against diet-induced NAFLD and atherosclerosis in LDLR-/- mice by reducing insulin resistance, suppressing de novo lipogenesis, and enhancing HDL biogenesis and turnover.